Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Granata Bio Acquires Oviva Therapeutics | Contract Pharma

What are you searching for?

Sign in
Breaking News

Granata Bio Acquires Oviva Therapeutics

Oviva's lead candidate, OVI-586, is a first-in-class therapeutic designed to enhance women's health span by extending ovarian function.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Granata Bio has acquired Oviva Therapeutics Inc., a women’s health biotech company focused on advancing treatments that address female physiology, with an emphasis on ovarian aging.

Oviva’s lead candidate, OVI-586, is a first-in-class therapeutic designed to enhance women’s health span—the period of life spent in optimal health—by extending ovarian function. OVI-586 holds potential applications across menopause, contraception, and in vitro fertilization (IVF), offering new possibilities for patients seeking advanced reproductive and endocrine health solutions.

“The acquisition of Oviva Therapeutics marks a significant milestone in our efforts to bring forward new therapies for those with limited treatment options,” said Evan Sussman, Co-Founder and CEO of Granata Bio. “In IVF stimulation, OVI-586 offers a biologically grounded approach to improving ovarian response—even in patients with diminished ovarian reserve. We’re excited to continue advancing OVI-586 and explore its potential in assisted reproductive technology (ART) and beyond.”

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics